50 Clinical Studies

50 Clinical Studies 50 Clinical Studies

Clinically proven to lower cholesterol, over 50 clinical trials, including long-term and high-dosage trials in different groups, have proven the efficacy and safety of plant sterols. Flora ProActiv foods contain the recommended plant sterol amount when eaten daily as directed.

There is a continuous dose-response relationship between the intake of plant sterols and their effect on elevated cholesterol levels up to a dosage of 2 to 2.5g of plant sterols per day. Intakes above 3g per day are not recommended, as this provides little further benefit. The scientific evidence for plant sterol efficacy has been independently reviewed by the European Food Safety Authority (EFSA).

National and international guidelines for cholesterol lowering now recommend 2g of plant sterols per day, as part of a healthy diet, to reduce cholesterol.

Recommended amount

1.5 to 2.4g of plant sterols a day is the recommended amount for cholesterol lowering*. You can get this amount from 3 portions of Flora ProActiv foods. One portion is about two teaspoons of spread (10g) or one glass of milk drink. A Flora ProActiv mini drink, however, gives you the full daily amount in just one drink.

*Flora ProActiv contains plant sterols. Plant sterols have been shown to lower blood cholesterol. High cholesterol is a risk factor in the development of coronary heart disease. Consuming 1.5-2.4g of plant sterols per day can lower cholesterol by 7-10% in 2-3 weeks when consumed as part of a healthy diet and lifestyle with sufficient fruit and vegetables.

References:

  1. Commission Regulation (EU) No 686/2014 as 20 June 2014 amending Regulations (EC) No 983/2009 and (EU) No 384/2010 as regards the conditions of use of certainĀ health claims related to the lowering effect of plant sterols and plant stanols on blood LDL-cholesterol.
  2. Catapano AL, et al. (2016) ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis 2016;253:281-344.